SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-009769
Filing Date
2024-03-13
Accepted
2024-03-13 08:02:27
Documents
72
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1395476
2 ex10-8.htm EX-10.8 130802
3 ex23-1.htm EX-23.1 6203
4 ex31-1.htm EX-31.1 20198
5 ex31-2.htm EX-31.2 20434
6 ex32-1.htm EX-32.1 7756
7 ex32-2.htm EX-32.2 7747
8 ex97-1.htm EX-97.1 32224
9 form10-k_002.jpg GRAPHIC 68346
10 form10-k_003.jpg GRAPHIC 60228
11 form10-k_004.jpg GRAPHIC 34683
12 form10-k_005.jpg GRAPHIC 49359
13 form10-k_006.jpg GRAPHIC 55493
14 form10-k_007.jpg GRAPHIC 30209
15 form10-k_008.jpg GRAPHIC 55311
  Complete submission text file 0001493152-24-009769.txt   5918143

Data Files

Seq Description Document Type Size
16 XBRL SCHEMA FILE indp-20231231.xsd EX-101.SCH 31864
17 XBRL CALCULATION FILE indp-20231231_cal.xml EX-101.CAL 49342
18 XBRL DEFINITION FILE indp-20231231_def.xml EX-101.DEF 103769
19 XBRL LABEL FILE indp-20231231_lab.xml EX-101.LAB 287090
20 XBRL PRESENTATION FILE indp-20231231_pre.xml EX-101.PRE 219283
73 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 492610
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40652 | Film No.: 24744619
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)